The Medical Marijuana Information Resource Centre is established to provide patients, caregivers, and clinicians with a source of scientific and current information about the use of marijuana (cannabis) as a medicine.
Logographic
ButtonButtonButtonButtonButton

News & Media

March 22, 2007 Cannabinoid market forecast at over $700 million Pharma Marketletter
With four drugs now in the marketplace (a 100% rise from two years ago), the cannabinoid market continues to grow, says a new report from Visiongain, which values the market for such drugs at $709.5 million at present, up from $386.7 million in 2006.  
March 1, 2007 Marijuana as wonder drug The Boston Globe
A new study in the journal Neurology is being hailed as unassailable proof that marijuana is a valuable medicine. It is a sad commentary on the state of modern medicine - and US drug policy - that we still need "proof" of something that medicine has known for 5,000 years.   
February 15, 2007 GW Partners Sativex With Otsuka In Potential $273M Deal BIOWORLD Today
GW Pharmaceuticals plc handed over development and U.S. marketing rights to its cannabinoid cancer pain compound to Otsuka Pharmaceutical Co. Ltd. in a deal that brings GW $18 million up front, along with milestone payments that could add $255 million.   
Medical Marijuana in Canada
Find out how medical marijuana is used legally and safely by many patients across Canada.

The Therapeutic Uses of Cannabinoids
Cannabis and cannabinoid-based drugs have been successfully used to treat a range of conditions and symptoms.
How to Access Medical Marijuana Legally in Canada
Are you eligible to apply for legal access under Canada's MMAR program?
About the Resource Centre
Learn about the Medical Marijuana Information Resource Centre.